ProCE Banner Activity

CE / CME

Systemic Mastocytosis Mayhem: Clinical Data on New and Emerging Therapies

Video

On-demand webcast of expert faculty presentation and patient case discussion on managing patients with systemic mastocytosis as well as integrating new and emerging therapies in your practice.

Nurse Practitioners/Nurses: 0.50 Nursing contact hours, includes 0.50 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Released: May 16, 2025

Expiration: May 15, 2026

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners), in partnership with the Coalition of Skin Diseases (CSD)

ProCE Banner

Supporters

Supported by an educational grant from Blueprint Medicines.

Blueprint Medicines

Partners

Coalition of Skin Diseases (CSD)

ProCE Banner

Target Audience

This educational activity is intended for dermatology NPs and PAs, as well as other NPs and PAs, such as those practicing in primary care, who are engaged in the care of patients with systemic mastocytosis.

Program Learning Goal

The goal of this educational activity is to improve the knowledge and competence of NP and PA learners in managing patients with systemic mastocytosis.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Recognize SM potential diagnosis in patients presenting with a wide range of unexplained symptoms to reduce delays in treatment

  • Implement expert guideline recommended criteria into the diagnosis and subtyping of SM

  • Appraise the clinical safety and efficacy data for new and emerging targeted therapies for SM

  • Develop patient education and shared decision-making strategies to reduce the associated burden of SM

Disclosure

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Primary Author

Jonathan A. Bernstein, MD: researcher: Blueprint Medicine, Celldex, Cogent, Telios; consultant/advisor/speaker: Celldex.

Kristine J. Kucera, PA-C, MPAS, DHS: consultant/advisor/speaker: AbbVie, Amgen, Arcutis, Beiersdorf, Bristol Myers Squibb, Ferndale, Galderma, Johnson & Johnson, Leo, Novartis, Pfizer, Sun, UCB.

Martha L. Sikes, DMSc, RPh, PA-C: consultant/advisor/speaker: Ortho Dermatologics.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 16, 2025, through May 15, 2026:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and the Coalition of Skin Diseases (CSD). Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours, including 0.5 hours of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until May 15, 2026. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.